NCT02290977 Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase PHASE2
NCT02289300 A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients Status WITHDRAWN Phase PHASE2
NCT02288910 Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver Status COMPLETED Phase N/A
NCT02279719 A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02273362 Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Status COMPLETED Phase PHASE1/PHASE2
NCT02269995 Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT02267213 Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma Status TERMINATED Phase PHASE2
NCT02259647 Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma Status COMPLETED Phase NA
NCT02253511 A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma Status UNKNOWN Phase PHASE4
NCT02243384 Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma Status COMPLETED Phase NA
NCT02240771 Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2/PHASE3
NCT02240433 A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC) Status COMPLETED Phase PHASE1
NCT02238769 18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma Status UNKNOWN Phase N/A
NCT02232633 A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer Status COMPLETED Phase PHASE2
NCT02232490 Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L Status UNKNOWN Phase PHASE3
NCT02220088 The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial Status TERMINATED Phase PHASE2/PHASE3
NCT02210182 A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma Status COMPLETED Phase PHASE1